Role of Platelets as a Factor Aggravating Cerebral Ischemia

Japanese Circulation Journal

Volumn 54, Issue 12, 1990, Pages 1511-1516

  Katayama, Yasuo ^a   Terashi, Akiro ^a   Shimizu, Jun ^a   Suzuki, Satoru ^a   Kashiwagi, Fumihiko ^a   Kamiya, Tatsuji ^a   Ashida, Shinichiro ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATAPROST; ENZYME INHIBITOR; LACTIC ACID; OZAGREL; PROSTACYCLIN DERIVATIVE; THROMBOXANE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; BRAIN ISCHEMIA; BRAIN METABOLISM; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PREVENTION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIA;

EID: 0025608464     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.54.12_1511     Document Type: Article

References (29)

1. BAZAN NG: Effect of ischemia and electroconvulsive shock on free fatty acid pool in the brain. Biochim Biophys Acta 218: 1, 1970
2. YOSHIDA S, INO S, ASANO T, SANO K, KUBOTA M, SIMAZAKI H, UETA N: Effect of transient ischemia on free fatty acids and phospholipids in the gerbil brain: Lipid peroxydation as a possible cause of postischemic injury. / Neurosurg 53: 323, 1980
3. WOLFE LS: Eicosanoids: Prostaglandins, thromboxanes, leukotrienes, and other derivatives of carbon-20 unsaturated fatty acids. J Neurochem 38: 1, 1982
4. HAMBERG M, SVENSSON J, SAMUELSSON B: Thromboxanes: A new group of biologically active compounds derived from prostaglandin en-doperoxides. Proc Natl Acad Sci USA 72: 2994, 1975
5. 2 and prostacyclin. Pharmacol Rev 30: 293, 1979
6. EBBE S, STOHLMAN F, OVERCASH J, DONOVAN J, HOWARD D: Megakaryocyte size in thrombocytopenic and normal rats. Blood 32: 383, 1968
7. ASHIDA S, ABIKO Y: Protective effect of panthethin on experimental thrombocytopenia in the rat. Thromb Diath Heamorrh 33: 528, 1975
8. ADAIKAN PG, KOTTEGODA SR, LAU LC, TAI MY, KARIM SMM: Inhibition of platelet aggregation and reversal of vasopressin-induced ECG changes by a carboprostacyclin analogue, ONO 41483, in primates. Prostaglandins Leukotrienes Med 9: 307, 1982
9. ADAIKAN PG, LAU LC, TAI MY, KARIM SMM: Inhibition of platelet aggregation with intravenous and oral administration of a carboprostacyclin analogue, 15-cyclopentyl-≪*≫-pentanor-5-(E) D-carbacyclin (ONO 41483) in man. Prostaglandins Leukotrienes Med 10: 53, 1983
10. TANOUCHI T, KAWAMURA M, OHYAMA I, KAJIWARA K, IGUCHI Y, OKADA T, TANI-GUCHI K, HAYASHI M, IIZUKA K, NAKA-ZAWA M: Highly selective inhibitors of thromboxane synthetase (II): Pyridine derivatives. J Med Chem 24: 1149, 1981
11. NAITO J, KOMATSU H, UJIIE A, HAMANO S, KUBOTA T, TSUBOSHIMA M: Effets of thromboxane synthetase inhibitors on aggregation of rabbit platelets. Eur J Pharmacol 91: 41, 1983
12. KATAYAMA Y, SUGIMOTO S, INAMURA K, SOEDA T, SHIMIZU J, SUZUKI S, NAGAZU-MI A, TERASHI A: Susceptibility to ischemic insult in hypertensive rats: Correlation between degree of ischemia and hypertension. Jpn Circ J 50: 258, 1986
13. KATAYAMA Y, SUGIMOTO S, SUZUKI S, SHIMIZU J, TERASHI A: Effect of lowering the blood pressure on acutely-induced experimental cerebral ischemia in SHR. Jpn J Stroke 9: 291, 1987
14. 2 synthetase inhibitor (Trapidil) on acutely-induced cerebral ischemia. Brain and Nerve 38: 925, 1986
15. HARKER LA, RITCHIE JL: The role of platelets in acute vascular events. Circulation 62 (Suppl 5): 13, 1980
16. MUSTARD JF, MOVAT HZ, MACORINE RL, SENYI A: Release of permeability factors from the blood platelets. Proc Soc Exp Biol and Med 119: 988, 1965
17. FUJIMOTO T, SUZUKI H, TANOUE K, FUKUSHIMA Y, YAMAZAKI H: Cerebrovascular injuries induced by activation of platelets in vivo. Stroke 16: 245, 1985
18. FISHI C, VOLANTE F, BATTISTINI N: A model of focal brain ischemia obtained by intracar-otid ADP infusion in rabbits. In Pathology of Cerebral Microcirculation, ed by CERVOS-NAVARRO J, Walter de Gruiter, Berlin, 1974, p 251
19. MEMEZAWA H, KATAYAMA Y, SUGIMOTO S, INAMURA K, SHIMIZU J, SOEDA T, SUZUKI S, TERASHI A: Arachidonic acid-induced brain ischemia: Different severity between stroke-resistant spontaneously hypertensive rats and Wistar-Kyoto rats. J Hypertension 4 (Suppl 3): 421, 1986
20. GOTOH F, FUKUUCHI Y, AMANO T, TANA-KA K, SUZUKI N, UEMATSU D, KAWAMURA J, YAMAWAKI T, TURCANI P: Visualization of platelets aggregation in the pial vessels in situ: Effect of middle cerebral artery occlusion. J Cereb Blood Flow Metab 5 (Suppl) 381, 1985
21. DENTON IC, ROBERTSON JT, DUGDALE M: An assessment of early platelets activity in experimental subarachnoid hemorrhage and middle cerebral artery thrombosis in the cat. Stroke 2: 268, 1971
22. SMITH JB, WILLIS AL: Formation and release of prostaglandins of platelets in release of thrombin. Br J Pharmacol 40: 545, 1976
23. 2. Stroke 8: 480, 1977
24. GORDON JL, MILNER AL: Blood platelets as multifunctional cells. In Platelets in Biology and Pathology, ed by GORDON JL, North Holland Pub. Co. Amsterdam, 3, 1976
25. MAJNO G, GILMORE V, LEVINTHAL M: On the mechanism of vascular leakage caused by histamine-type mediators. Circ Res 21: 832, 1967
26. GAUDET RJ, ALAM I, LEVINE L: Accumulation of cyclooxygenase products of arachidonic acid metabolism in gerbil brain during reperfusion after bilateral common carotid artery occlusion. J Neurochem 35: 653, 1980
27. SHOHAMI E, ROSENTHAL J, LAVY S: The effect of incomplete cerebral ischemia on prostag-landin levels in rat brain. Stroke 13: 494, 1982
28. 2 synthetase inhibitor (OKY-046) on experimental cerebral vasospasm. Okayamaigakukai Zasshi 96: 149, 1984
29. 2 synthetase inhibitor, on experimental cerebral vasospasm. J Pharmacol 41: 381, 1986